Global Cardiovascular Repair And Reconstruction Devices Market by Product (Heart Valve Repair, Patches, Graft) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast To 2028

Summary of the Report

Global cardiovascular repair and reconstruction device market was worth USD 2,831.1 millions in 2016. It is forecast to grow at 5.2% CAGR over the forecast period. Market growth is attributed to the rise in Congenital Heart Diseases (CHDs), and technological advances in molecular and clinical pharmacology, vascular surgery, and cell biology.

The American Heart Association estimates that Cardiovascular Diseases (CVDs), which account for almost 800,000 deaths each year in the United States, were a leading cause of death in 2015. Around 85.6 million Americans suffer from strokes or other forms of CVD. It is one the leading causes of death worldwide. CVDs were responsible for 31% of all global deaths in 2015. Nearly 17.7 people died from them in 2015. In the United States, mild CHD is on the rise. Nearly 25% percent of CHD-infected babies develop critical CHD within their first year. This needs to be treated with medication or surgery. The market for cardiovascular repair devices is expected to grow significantly over the forecast period.

The development of new products, designs, raw materials sourcing, fabrication, clinical evaluations, preservation solutions and preservation techniques has resulted in the creation of technologically advanced products. Gore Medical introduced ePTFE for the manufacture of cardiovascular patches. The market for cardiovascular reconstruction devices is growing because of the increased use of ePTFE patches in a variety of applications.

Additionally, clinical trials are being conducted to examine the application of patches. CryoLife's SynerGraft, a decellularization technology that is used to process pulmonary valves or pulmonary cardiac patch tissue tissues, is another example. SynerGraft allows for the virtual elimination or modification of allergic donor cells.

The demand for tissue valves has increased with the introduction of Transcatheter Valves. Transcatheter Aortic Valve Implantation or Transcatheter Aortic Valve Replacement is an FDA-approved procedure used in the replacement of heart valves for the treatment symptomatic aortic stenosis. Edwards Lifesciences, Medtronic and Medtronic are two of the major players in the TAVR market. JenaValve, a German-based company, has successfully completed the CE mark study for their next-generation JenaValve Pericardial TACVR system. They expect to launch a limited launch in a few European countries and regions compatible with CE marking within the next few quarters. The market will see significant growth over the next few years as new players enter the scene with the most advanced technology.

The market for cardiovascular repair devices is also growing due to technologically advanced cryopreservation methods. They preserve animal tissue for longer periods of time and play a critical role in increasing their lifespan. These technological developments are positively impacting the market growth through boosting demand for cardiac grafts and patches.

Product Insights

The highest market share was held by the segment of cardiovascular grafts as of 2016. This is due to increased use of grafts during surgeries. These products are being used in more pediatric surgeries due to the rise in CHDs such as double-outlet ventricles and atrial septal defect. Endovascular stents grafts have emerged as the largest segment within this segment due to their increased use in vascular surgery, particularly for treatment of abdominal and thoracic aortic aneurysms.

The global market for heart valve repair was approximately 12% in 2016. Heart valve surgery is generally performed to treat heart disease and prolong life. Restoring heart tissue and fixing the valve is a common goal. Edwards Sapien TAVR and the enCorSQ mitral valve repair system by MiCardia Corporation are two examples of valve repair devices.

With a 6.4% CAGR over the forecast period, the cardiovascular patches segment will be the fastest-growing. The market will be driven by the reduction in adverse effects of technologically advanced, xenogenicpericardial patch technology. These devices can be used for tissue repair, vascular repair and reconstruction, as well as dural repair.

Regional Insights

North America was the dominant market for cardiovascular repair and reconstruction devices in 2016. Due to the increasing aging population and poor lifestyle, there is a high incidence of cardiovascular disease. The region's high economic development, well-equipped hospitals, medical device makers, universities, and research centers are key factors in promoting new product development and commercialization. Growth is also supported by well-established reimbursement policies, and a sophisticated healthcare infrastructure.

In 2016, over 40% of total revenue was held by the United States. Chronic conditions such as diabetes, arthritis, cancer, and other cardiovascular diseases are increasing. This market is driven by the availability of technology-advanced products in many fields such as cell biology, molecular chemistry, and cardiovascular surgery, as well as an increase in congenital heart disease, such right ventricular output tract and ventricular septal defect.

Asia Pacific will experience the fastest growth during the forecast period. China, India and other emerging economies are leading the charge due to their large populations, changing lifestyles, high unmet health care needs, and changing lifestyles. The market is also growing due to improvements in the healthcare infrastructure. Market growth will also be supported by the increasing interest of international players to expand to this region.

Market Share Insights & Key Companies

Medtronic, Bard Peripheral Vascular, Terumo Cardiovascular Systems Corporation, W. L. Gore & Associates, Inc., Getinge AB, CryoLife, Inc., Edwards Lifesciences Corporation, Baxter, and Admedus are some of the major players in this market. One of the most important indicators of competition is the increasing number of mergers and acquisitions made by key players such as Terumo Cardiovascular or Medtronic to increase market share. Medtronic acquired Covidien in 2014. In 2014, Covidien bought the Reverse Medical Corporation vascular products product line. The amount of the merger was not disclosed. Terumo Corporation, which is based in Japan, purchased Bolton Medical, Inc., from its parent company in 2017 to expand its product portfolio in the U.S. and the global stent market.

Market Report Scope Cardiovascular Repair and Reconstruction Devices

The Report Covers Certain Segments

This report predicts revenue growth at the global, regional and country levels. It also provides analysis of industry trends in each sub-segment from 2014 through 2025. Grand View Research has divided the global market for cardiovascular repair and reconstruction devices on the basis product type and location.

• Product Outlook (Revenue USD Million, 2014-2025)

  • Heart Valve Repair

  • Cardiovascular Grafts

    • Endovascular stent graft

    • Access to hemodialysis graft

    • Peripheral vascular graft

  • Cardiovascular patches

    • By Application

      • Cardiac repair patches

        • Atrial septal defect

        • Common atrium

        • Endocardial cushion defects

        • Ventricular septal defect

        • Tetralogy of Fallot

        • Suture bleeding

      • Vascular Repair Patches

        • Carotid endarterectomy

        • Anomalous connections of the pulmonary veins

        • Transport of great vessels

        • Reconstruction of the portal, superior mesenteric veins and the portal

        • Other

    • By raw material

      • Synthetic patches

      • Biological patches

These are the most frequently asked questions about this report

b. Global market for cardiovascular repair and reconstruction devices was valued at USD 3.3 billion in 2019, and is forecast to grow to USD 3.5 billion by 2020.

b. Global cardiovascular repair and reconstruction device market is expected grow at a compound annual rate of 5.2 percent from 2019 to 2025, to reach 4.48 Billion by 2025.

b. The heart valve repair segment dominated the cardiovascular market with 12.0% of the share in 2019.

b. Medtronic, Bard Peripheral Vascular, Terumo Cardiovascular Systems Corporation, W. L. Gore & Associates, Inc., Getinge AB, CryoLife, Inc., Edwards Lifesciences Corporation are some of the key players in the market for cardiovascular repair and reconstruction.

b. Market growth is being driven by the increasing prevalence of Congenital Heart Defects, as well as technological advances in molecular and clinical pharmacology and cell biology.

Up Market Research published a new report titled “Cardiovascular Repair And Reconstruction Devices Market research report which is segmented by Product (Heart Valve Repair, Patches, Graft), By Players/Companies Inc, Terumo Cardiovascular Systems Corporation, Edwards Lifesciences Corporation, Inc, CryoLife, W L Gore & Associates, Bard Peripheral Vascular, Medtronic, Getinge AB”. As per the study the market is expected to grow at a CAGR of XX% in the forecast period.

The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.

Global Cardiovascular Repair And Reconstruction Devices Market Report Segments:

The market is segmented by Product (Heart Valve Repair, Patches, Graft).

Cardiovascular Repair And Reconstruction Devices Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.

Key Benefits for Industry Participants & Stakeholders:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Cardiovascular Repair And Reconstruction Devices Market

Overview of the regional outlook of the Cardiovascular Repair And Reconstruction Devices Market:

Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.

Highlights of The Cardiovascular Repair And Reconstruction Devices Market Report:

1. The market structure and projections for the coming years.
2. Drivers, restraints, opportunities, and current trends of Cardiovascular Repair And Reconstruction Devices Market.
3. Historical data and forecast.
4. Estimations for the forecast period 2028.
5. Developments and trends in the market.

                1. Heart Valve Repair

                2. Patches

                3. Graft

7. Market scenario by region, sub-region, and country.
8. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
9. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
10. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Cardiovascular Repair And Reconstruction Devices Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.

How you may use our products:

• Correctly Positioning New Products
• Market Entry Strategies
• Business Expansion Strategies
• Consumer Insights
• Understanding Competition Scenario
• Product & Brand Management
• Channel & Customer Management
• Identifying Appropriate Advertising Appeals

Reasons to Purchase the Cardiovascular Repair And Reconstruction Devices Market Report:

• The report includes a plethora of information such as market dynamics scenario and opportunities during the forecast period
• Segments and sub-segments include quantitative, qualitative, value (USD Million,) and volume (Units Million) data.
• Regional, sub-regional, and country level data includes the demand and supply forces along with their influence on the market.
• The competitive landscape comprises share of key players, new developments, and strategies in the last three years.
• Comprehensive companies offering products, relevant financial information, recent developments, SWOT analysis, and strategies by these players.